MediPharm Labs (TSE:LABS) Shares Down 6.7% – Time to Sell?

MediPharm Labs Corp. (TSE:LABSGet Free Report) shares fell 6.7% on Thursday . The stock traded as low as C$0.07 and last traded at C$0.07. 107,441 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 376,219 shares. The stock had previously closed at C$0.08.

MediPharm Labs Trading Down 6.7 %

The company has a quick ratio of 3.10, a current ratio of 3.11 and a debt-to-equity ratio of 5.90. The stock’s 50 day moving average is C$0.07 and its 200-day moving average is C$0.07. The company has a market cap of C$28.77 million, a PE ratio of -1.75 and a beta of 0.88.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Read More

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.